Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Newly discovered protein modulates GABA, benzodiazepines

Oct. 17, 2019

Bi-allelic loss of human APC2 is associated with recessive form of lissencephaly

Oct. 17, 2019

Preclinical evaluation of novel nonimmunogenic utrophin gene therapy for DMD

Oct. 17, 2019

Milasen, individualized gene therapy for rare genetic disease

Oct. 17, 2019

Anticoagulants prevent AD symptoms

Oct. 17, 2019

AL-S Pharma initiates phase I study of AP-101 in ALS

Oct. 16, 2019

Pfizer identifies muscarinic acetylcholine M4 receptor agonists

Oct. 16, 2019

New eukaryotic translation initiation factor 2B activators patented by Denali Therapeutics

Oct. 16, 2019

Kappa-opioid receptor antagonists presented by the University of Kansas, University of Florida

Oct. 16, 2019

Yumanity Therapeutics discloses SCD1/SCD5 inhibitors

Oct. 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...